Replies to post #224 on Precision BioSciences Inc (DTIL)

[jondoeuk]

Now they are promising to give an update on azer-cel "once sufficient follow-up supports meeting FDA to discuss clinical plans,'' so April or May. So much for Q1! As for 19B, that April or May update will include data from DL2, with ''expectation of durability data to follow this year."